U.S. Molecular Biology Enzymes, Reagents and Kits Market Size, Share, Trends, & Industry Analysis Report By Product (Kits & Reagents and Enzymes), By Application, and By End User- Market Forecast, 2025-2034

Description

List of Tables

The U.S. molecular biology enzymes, reagents, and kits market size is expected to reach USD 15.25 Billion by 2034, according to a new study by Polaris Market Research. The report "US Molecular Biology Enzymes, Reagents and Kits Container Market Share, Size, Trends, Industry Analysis Report: By Product (Kits & Reagents and Enzymes), By Application, and By End User; Market Forecast, 2025-2034" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The demand for molecular biology enzymes, reagents, and kits in the US is rising due to its role in clinical diagnostics, genomic research and pharmaceutical development. These products support accurate, reproducible and high-throughput workflows across applications such as digital PCR, sequencing, cloning and gene expression analysis.

The market is driven by growing federal research funding, expanding biopharmaceutical R&D and the adoption of precision medicine. Furthermore, advancements in enzyme engineering, contamination-free kits and increasing use of automation-compatible consumables across academic and clinical laboratories are driving market growth.

U.S. Molecular Biology Enzymes, Reagents and Kits Container Market Report Highlights

Based on product, the kits and reagents segment dominated the market in 2024. This is driven by their broad application in standardized workflows across clinical, academic, and industrial laboratories.

In terms of application, the PCR segment dominated the market in 2024, due to its wide use in disease diagnostics, gene expression analysis, and public health surveillance.

In terms of end user, the pharmaceutical and biotechnology companies segment held the largest market share in 2024, driven by increased R&D spending, rising demand for GMP-grade reagents, and expanding biomanufacturing activities.

A few key market players include Thermo Fisher Scientific Inc., Merck KGaA, New England Biolabs, Inc., Agilent Technologies Inc., Promega Corporation, Takara Bio USA, Inc., QIAGEN Inc., Bio-Rad Laboratories, Inc., Enzo Life Sciences, Inc., Lucigen Corporation, Boster Biological Technology, and LGC Biosearch Technologies.

Polaris Market Research has segmented the market report on the basis of product, application, end user channel, and country:

By Product Outlook (Revenue, USD Billion, 2020-2034)

Kits & Reagents

Enzymes

Polymerases

Ligases

Restriction Endonucleases

Reverse Transcriptase's

Phosphatases

Proteases and Proteinases

Other Enzymes

By Application Outlook (Revenue, USD Billion, 2020-2034)

Sequencing

Cloning

Polymerase Chain Reaction (PCR)

Restriction Digestion

Synthetic Biology

Epigenetics

Other Application

By End User Channel Outlook (Revenue, USD Billion, 2020-2034

Academic and Research Institutes

Pharmaceutical and Biotechnology Companies

Hospitals and Diagnostic Laboratories

Contract Research Organizations (CROs)

Forensic Laboratories

Food and Agriculture Research Centers

Environmental Testing Labs

Product Code: PM6103

1. Introduction

1.1. Report Description
- 1.1.1. Objectives of the Study
- 1.1.2. Market Scope
- 1.1.3. Assumptions
1.2. Stakeholders

2. Executive Summary

2.1. Market Highlights

3. Research Methodology

3.1. Overview
- 3.1.1. Data Mining
3.2. Data Sources
- 3.2.1. Primary Sources
- 3.2.2. Secondary Sources

4. U.S. Molecular Biology Enzymes, Reagents and Kits Market Insights

4.1. Molecular Biology Enzymes, Reagents and Kits Market - Market Snapshot
4.2. Molecular Biology Enzymes, Reagents and Kits Market Dynamics
- 4.2.1. Drivers and Opportunities
  - 4.2.1.1. Rising Prevalence of Chronic and Infectious Diseases
  - 4.2.1.2. Increasing Federal Research Funding Boost Market Growth
- 4.2.2. Restraints and Challenges
  - 4.2.2.1. High Cost of High-Purity Enzymes
4.3. Porter's Five Forces Analysis
- 4.3.1. Bargaining Power of Suppliers (Moderate)
- 4.3.2. Threats of New Entrants: (Low)
- 4.3.3. Bargaining Power of Buyers (Moderate)
- 4.3.4. Threat of Substitute (Moderate)
- 4.3.5. Rivalry among existing firms (High)
4.4. PESTEL Analysis
4.5. Molecular Biology Enzymes, Reagents and Kits Market Trends
4.6. Value Chain Analysis

5. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Product

5.1. Key Findings
5.2. Introduction
- 5.2.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Product, 2020-2034 (USD Billion)
5.3. Kits & Reagents
- 5.3.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Kits & Reagents, by Country, 2020-2034 (USD Billion)
5.4. Enzymes
- 5.4.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Enzymes, by Country, 2020-2034 (USD Billion)

6. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Application

6.1. Key Findings
6.2. Introduction
- 6.2.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Application, 2020-2034 (USD Billion)
6.3. Sequencing
- 6.3.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Sequencing, by Country, 2020-2034 (USD Billion)
6.4. Cloning
- 6.4.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Cloning, by Country, 2020-2034 (USD Billion)
6.5. Polymerase Chain Reaction (PCR)
- 6.5.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Restriction Digestion, by Country, 2020-2034 (USD Billion)
6.6. Restriction Digestion
- 6.6.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Restriction Digestion, by Country, 2020-2034 (USD Billion)
6.7. Synthetic Biology
- 6.7.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Synthetic Biology, by Country, 2020-2034 (USD Billion)
6.8. Epigenetics
- 6.8.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Epigenetics, by Country, 2020-2034 (USD Billion)
6.9. Other Application
- 6.9.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Other Application, by Country, 2020-2034 (USD Billion)

7. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by End User

7.1. Key Findings
7.2. Introduction
- 7.2.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by End User, 2020-2034 (USD Billion)
7.3. Academic and Research Institutes
- 7.3.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Academic and Research Institutes, by Country, 2020-2034 (USD Billion)
7.4. Pharmaceutical and Biotechnology Companies
- 7.4.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Pharmaceutical and Biotechnology Companies, by Country, 2020-2034 (USD Billion)
7.5. Hospitals and Diagnostic Laboratories
- 7.5.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Hospitals and Diagnostic Laboratories, by Country, 2020-2034 (USD Billion)
7.6. Contract Research Organizations (CROs)
- 7.6.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Contract Research Organizations (CROs), by Country, 2020-2034 (USD Billion)
7.7. Forensic Laboratories
- 7.7.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Forensic Laboratories, by Country, 2020-2034 (USD Billion)
7.8. Food and Agriculture Research Centers
- 7.8.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Food and Agriculture Research Centers, by Country, 2020-2034 (USD Billion)
7.9. Environmental Testing Labs
- 7.9.1. U.S. Molecular Biology Enzymes, Reagents and Kits Market, by Environmental Testing Labs, by Country, 2020-2034 (USD Billion)

8. Competitive Landscape

8.1. Expansion and Acquisition Analysis
- 8.1.1. Expansion
- 8.1.2. Acquisitions
8.2. Partnerships/Collaborations/Agreements/Exhibitions

9. Company Profiles

9.1. Agilent Technologies Inc.
- 9.1.1. Company Overview
- 9.1.2. Financial Performance
- 9.1.3. Product Benchmarking
- 9.1.4. Recent Development
9.2. Bio-Rad Laboratories, Inc.
- 9.2.1. Company Overview
- 9.2.2. Financial Performance
- 9.2.3. Product Benchmarking
- 9.2.4. Recent Development
9.3. Boster Biological Technology
- 9.3.1. Company Overview
- 9.3.2. Financial Performance
- 9.3.3. Product Benchmarking
- 9.3.4. Recent Development
9.4. Enzo Life Sciences, Inc.
- 9.4.1. Company Overview
- 9.4.2. Financial Performance
- 9.4.3. Product Benchmarking
- 9.4.4. Recent Development
9.5. LGC Biosearch Technologies
- 9.5.1. Company Overview
- 9.5.2. Financial Performance
- 9.5.3. Product Benchmarking
- 9.5.4. Recent Development
9.6. Lucigen Corporation
- 9.6.1. Company Overview
- 9.6.2. Financial Performance
- 9.6.3. Product Benchmarking
- 9.6.4. Recent Development
9.7. Merck KGaA
- 9.7.1. Company Overview
- 9.7.2. Financial Performance
- 9.7.3. Product Benchmarking
- 9.7.4. Recent Development
9.8. New England Biolabs, Inc.
- 9.8.1. Company Overview
- 9.8.2. Financial Performance
- 9.8.3. Product Benchmarking
- 9.8.4. Recent Development
9.9. Promega Corporation
- 9.9.1. Company Overview
- 9.9.2. Financial Performance
- 9.9.3. Product Benchmarking
- 9.9.4. Recent Development
9.10. QIAGEN Inc.
- 9.10.1. Company Overview
- 9.10.2. Financial Performance
- 9.10.3. Product Benchmarking
- 9.10.4. Recent Development
9.11. Thermo Fisher Scientific Inc.
- 9.11.1. Company Overview
- 9.11.2. Financial Performance
- 9.11.3. Product Benchmarking
- 9.11.4. Recent Development